TrialThe international journal of neuropsychopharmacology2023

Adverse Events and Measurement of Dissociation After the First Dose of Esketamine in Patients With TRD.

David Williamson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.